Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Is there any role in continuing apixaban in a patient with occlusion of the right internal jugular vein with chronic postthrombotic change to prevent a recurrent DVT?
Previous provoking factors resolved (CVC, malignancy, etc)
Answer from: at Academic Institution
Yes
Sign in or Register to read more
15620
Related Questions
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
How would you manage distal DVT in first trimester of pregnancy?
Does PT/PTT elevation due to severe vitamin K deficiency protect against thrombosis?
How long would you anticoagulate for PE developed after air travel in a woman on an estrogen-containing vaginal ring for contraception?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
Would you evaluate for thrombophilia in patients with incidental splenic infarcts in the setting of known cirrhosis, portal hypertension, and splenomegaly?
Would you recommend indefinite anticoagulation in any scenario of a provoked clot?